Table 3 The clinical and biochemical characteristics of rs1501299 polymorphism amongst two groups
Variablers1501299 (case/control)GT vs. GGTT vs. GGTT+GT vs. GGTT vs. GT+GG
GGGTTT
Sex
  Male75/10167/8615/111.05 (0.68, 1.63); 0.8301.84 (0.80, 4.23); 0.1531.14 (0.75, 1.73); 0.5441.80 (0.80, 4.03); 0.156
  Female99/13993/9622/191.36 (0.93, 2.00); 0.1171.63 (0.84, 3.16); 0.1531.40 (0.98, 2.02); 0.0681.42 (0.75, 2.70); 0.288
Age (years)
  <55108/148100/10718/181.28 (0.89, 1.85); 0.1881.37 (0.68, 2.76); 0.3771.29 (0.91, 1.84); 0.1531.23 (0.62, 2.42); 0.556
  ≥5566/9260/7519/121.12 (0.70, 1.77); 0.6452.21 (1.00, 4.86); 0.0491.27 (0.82, 1.96); 0.2932.10 (0.98, 4.48); 0.056
BMI (kg/m2)
  <2578/11684/8417/141.49 (0.98, 2.26); 0.0621.81 (0.84, 3.87); 0.1291.53 (1.03, 2.29); 0.0361.50 (0.72, 3.13); 0.282
  ≥2596/12476/9820/161.00 (0.67, 1.50); 0.9931.62 (0.79, 3.28); 0.1861.09 (0.74, 1.59); 0.6651.61 (0.81, 3.21); 0.172
  • Bold values are statistically significant (P<0.05).